|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation:final results of an international phase Ⅱ trial显示文摘 | Vitolo U Chiappella A Ferreri AJ | 2011 | J Clin Oncol2011，29，20： | 1 |
| 2 | Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-ceU lymphoma with a poor prognosis: a phase II multieenter study 显示文摘 | Vitolo U Chiappella A Angelucci E | 2009 | Haematologica2009，94，9： | 1 |
| 3 | First-line treatment for primary testicular diffuse large B-cell lym- phoma with rituximab-CHOP,CNS prophylaxis,and con- tralateral testis irradiation:final results o{ an internation- al phase lI trial 显示文摘 | Vitolo U Chiappella A Ferreri AJM | 2011 | J Clin Oncol2011，29，20： | 1 |
| 4 | Interim lSFDG-PET/ CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with ritux- imab-CHOP显示文摘 | Pregno P Chiappella A Bello M | 2012 | Blood2012，119，9： | 1 |
| 5 | FDG-PET in the detection of bone marrow disease in Hodgkin’s disease and aggressive non-Hodgkin’s lymphoma and its impact on clinical management显示文摘 | Pelosi E Penna D Deandreis D Chiappella A Skanjeti A Vitolo U Bisi G | 2008 | The Quarterly Journal of Nuclear Medicine and Molecular Imaging2008，，1： | 1 |
| 6 | Rituximab dose- dense chemotherapy followed by intensified high-dose chemotherapy and autologous stem cell transplantation (HDC+ ASCT) significantly reduces the risk of progression compared to standard rituximab dose-dense chemotherapy as first line treatment in young patients with high-risk (aa-IPl 2 3 ) diffuse large B-cell lymphoma (DLBCL): final results of phase III randomized trial DLCL04 of the Fondazione Italiana Linfomi (FIL) 显示文摘 | Vitolo U Chiappella A Brusamolino E | 2012 | Blood (ASH Annual Meeting Abstracts)2012，120，21： | 1 |
| 7 | Interim 18-FDG-PET/ CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab- CHOP显示文摘 | Pregno P Chiappella A Bell6 M | 2012 | Blood2012，119，8： | 1 |
| 8 | Lenalidomide plus R-CHOP21in elderly patients with untreated diffuse large B-cell lymphoma:results of the REAL07open-label,multicentre,phase 2 trial显示文摘 | Vitolo U Chiappella A Franceschetti S | 2014 | Lancet Oncol2014，15，： | 1 |
| 9 | First-line treatment for primary testicular diffuse large B-cell lymphoma with rit- uximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an intemational phase II trial 显示文摘 | Vitolo U Chiappella A Ferreri AJ | 2011 | J Clin Oncol2011，29，20： | 1 |
| 10 | The outcome of patients with diffuse large B-Cell lymphoma (DLBCL) treated with Ritux-imab-CHOP (R-CHOP) is not predicted by 18-FDG-Positron Emission Tomography/Computerized Tomography (PET) performed at intermediate in-course evaluation,but only by PET a显示文摘 | Vitolo U Chiappella A Bello M | | 0，，： | 1 |
| 11 | Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma:results of the REAL07 open-label,multicentre,phase Ⅱ trial显示文摘 | Vitolo U Chiappella A Franceschetti S | 2014 | Lancet Oncol2014，15，7： | 1 |
| 12 | Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP显示文摘 | Pregno P Chiappella A Bellò M | 2012 | Blood2012，119，9： | 1 |
| 13 | First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab CHOP,CNS prophylaxis,and contralateral testis irradiation:final results of an international phase Ⅱ trial显示文摘 | Vitolo U Chiappella A Ferreri AJM | 2011 | J Clin Oncol2011，29，： | 1 |
| 14 | Interim 18-FDG-PET/CT failed topredict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP显示文摘 | Pregno P Chiappella A Bellb M | 2012 | Blood2012，119，9： | 1 |
| 15 | First-line treatment for primary testicular diffuse large B- cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an in-ternational phase II trial显示文摘 | VITOLO U CHIAPPELLA A FERRERI A J | 2011 | J Clin Oncol2011，29，20： | 1 |
| 16 | Interim 18-FDG- PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximabCHOP显示文摘 | Pregno P Chiappella A Bello M | 2012 | Blood2012，119，9： | 1 |
| 17 | Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma pa- tients treated at the diagnosis with rituximab-CHOP 显示文摘 | Pregno P Chiappella A Bellb M | 2012 | Blood2012，119，： | 1 |
| 18 | Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP显示文摘 | Pregno P Chiappella A Bellò M | 2012 | Blood2012，119，： | 1 |
| 19 | First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximabCHOP,CNS prophylaxis,and contralateral testis irradiation:final results of an international phaseⅡtrial显示文摘 | Vitolo U Chiappella A Ferreri AJ | 2011 | J Clin Oncol2011，29，20： | 1 |
| 20 | Interim 18-FDG- PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with Rituximab- CHOP显示文摘 | Pregno P Chiappella A Bell6 M | 2012 | Blood2012，119，9： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员